TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23509040

Group type: EXPERIMENTAL
Intervention: DAS group (treating to a DAS28 of <2.6)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: 0-SJC group (treating to a 0 of 28 swollen joint count)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Routine Care (RC)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: DAS group
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: 0-SJC group
Number of subjects: 308
Study: 21462215

Group type: EXPERIMENTAL
Intervention: Q‐ter 320 mg + creatine 340 mg
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 18718555

Group type: EXPERIMENTAL
Intervention: Supported employment intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16931611

Group type: EXPERIMENTAL
Intervention: Parenteral carnitine supplementation (20 mg/kg/d) at week 1 (n = 6)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enteral carnitine supplementation (20 mg/kg/d) at week 8 (n = 8)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Paired analysis of parenteral at week 1 and enteral at week 8 (n = 5)
Number of subjects: 16
Study: 15302144

Group type: EXPERIMENTAL
Intervention: Exercise intervention (compensatory training, emphasizing enhancement of visual and somatosensory function, and balance training) administered three times weekly for 12 weeks.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo intervention (language development activities) administered three times weekly for 12 weeks.
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Merged data from both groups after exercise intervention.
Number of subjects: 21
Study: 11403983

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg/day PO
Number of subjects: 29

Group type: COMPARATOR
Intervention: Haloperidol 10 mg/day PO
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 29
Study: 9514556

Group type: EXPERIMENTAL
Intervention: Acceptance of pain
Number of subjects: 160
Study: 8087820

Group type: EXPERIMENTAL
Intervention: Nitrates (intravenous, oral, or transdermal)
Number of subjects: 80000

Group type: EXPERIMENTAL
Intervention: Nitrates (combined with lisinopril)
Number of subjects: 80000

Group type: COMPARATOR
Intervention: Control group (ACE-inhibition strategy)
Number of subjects: 80000
Study: 2832598

Group type: EXPERIMENTAL
Intervention: Continuous progestin (2.5 mg daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cyclic progestin (5 mg daily or 5 mg during the last 12 days of a 28-day cycle)
Number of subjects: 36
Study: 29890800

Group type: EXPERIMENTAL
Intervention: Anterior wall with screw and posterior with plate (SP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Anterior wall with plate and posterior wall with screw (PS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both wall with plate (PP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal control group (complete acetabulum)
Number of subjects: 16
Study: 27190539

Group type: EXPERIMENTAL
Intervention: BrainPower Advanced (n=47)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (n=51)
Number of subjects: 98
Study: 24398576

Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (frequency of 50 Hz, amplitude of 2 mm, four 1-min series with 1-min rest intervals in three body positions)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 43
Study: 23740686

Group type: EXPERIMENTAL
Intervention: Folic acid (FA) 500 µg daily for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 20646353

Group type: EXPERIMENTAL
Intervention: bLf 100 mg/twice/day
Number of subjects: 2

Group type: COMPARATOR
Intervention: Ferrous sulfate 520 mg/day
Number of subjects: 2
Study: 18403387

Group type: EXPERIMENTAL
Intervention: Septal ventricular lead implantation
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard apical pacing
Number of subjects: 98
Study: 16884565

Group type: EXPERIMENTAL
Intervention: e‐health application with a diabetes management system and a home care link
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual care (regular general practitioner visits every three months)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: e‐health application
Number of subjects: 175
Study: 12801195

Group type: EXPERIMENTAL
Intervention: Cold weather outdoor training (winter)
Number of subjects: 1405

Group type: COMPARATOR
Intervention: Warm weather outdoor training (summer)
Number of subjects: 1405
Study: 10825328

Group type: EXPERIMENTAL
Intervention: Thoracic paravertebral block (PVB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 60
Study: 8837669

Group type: EXPERIMENTAL
Intervention: SIT with standardized Dermatophagoides pteronyssinus extract
Number of subjects: 40
Study: 8469455

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted delivery
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Forceps-assisted delivery
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Spontaneous vaginal delivery
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Sequential vacuum and forceps-assisted delivery
Number of subjects: 278

Group type: COMPARATOR
Intervention: Fetal distress
Number of subjects: 278

Group type: COMPARATOR
Intervention: Decreased birth weight for gestation
Number of subjects: 278

Group type: COMPARATOR
Intervention: Umbilical artery pH less than 7.20
Number of subjects: 278

Group type: COMPARATOR
Intervention: Second stage of labor less than 30 minutes
Number of subjects: 278

Group type: COMPARATOR
Intervention: Vacuum-assisted delivery among low birth weight infants
Number of subjects: 278

Group type: COMPARATOR
Intervention: Short second stage of labor
Number of subjects: 278

Group type: COMPARATOR
Intervention: Fetal acidosis
Number of subjects: 278

Group type: COMPARATOR
Intervention: Sequential use of vacuum and forceps for assisted delivery
Number of subjects: 278
Study: 3780285

Group type: EXPERIMENTAL
Intervention: Conventional propranolol ('Inderal')
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol ('Inderal' LA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Both formulations of propranolol
Number of subjects: 13
Study: 28985685

Group type: EXPERIMENTAL
Intervention: Simultaneous stretching of the Achilles tendon and plantar fascia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stretching of the Achilles tendon only
Number of subjects: 50
Study: 27196818

Group type: EXPERIMENTAL
Intervention: Post-MRI ICD sensing and treatment of ventricular tachyarrhythmias (VT/VF)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Detection delay due to undersensing pre-MRI
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Detection delay due to undersensing post-MRI
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Pre-MRI episodes with detection delay
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Post-MRI episodes with detection delay
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Maximum detection delay pre-MRI
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Maximum detection delay post-MRI
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Clinically significant detection delay
Number of subjects: 156
Study: 24762413

Group type: EXPERIMENTAL
Intervention: Booster simulation 7 to 10 months after NRP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no booster simulation)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NICU program
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Non‐NICU program
Number of subjects: 50
Study: 23438041

Group type: EXPERIMENTAL
Intervention: PMTCT intervention
Number of subjects: 478

Group type: COMPARATOR
Intervention: Standard of care (health education sessions plus PMTCT)
Number of subjects: 478
Study: 18801832

Group type: EXPERIMENTAL
Intervention: 0.05 microg kg(‐1) min(‐1) remifentanil
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.15 microg kg(‐1) min(‐1) remifentanil
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 21
Study: 18426146

Group type: EXPERIMENTAL
Intervention: High-dose sublingual immunotherapy (SLIT) with a 6-grass pollen mixture, once daily for 2 years
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 16643482

Group type: EXPERIMENTAL
Intervention: Tolterodine extended-release (ER) 4 mg once daily
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 12794521

Group type: EXPERIMENTAL
Intervention: G‐CSF
Number of subjects: 67
Study: 10984368

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) 400 microg once daily
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) 200 microg twice daily
Number of subjects: 306

Group type: COMPARATOR
Intervention: Mometasone furoate (MF) 200 microg once daily
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study: 8784105

Group type: EXPERIMENTAL
Intervention: Leuprolide 10 micrograms/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nafarelin 100 micrograms
Number of subjects: 0
Study: 1453146

Group type: EXPERIMENTAL
Intervention: Clarithromycin, 250 mg twice daily
Number of subjects: 453

Group type: COMPARATOR
Intervention: Penicillin VK, 250 mg three times daily
Number of subjects: 453
Study: 6660217

Group type: EXPERIMENTAL
Intervention: 1 g/kg guava juice (acute i.p. treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral administration of guava juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorpropamide and metformin (control)
Number of subjects: 0
Study: 31536556

Group type: EXPERIMENTAL
Intervention: Everolimus (5-10 ng/mL) with mycophenolic acid (MPA) and basiliximab
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (CNI-based regimen with mycophenolic acid (MPA) and cyclosporine
Number of subjects: 207
Study: 29914943

Group type: EXPERIMENTAL
Intervention: Fluconazole (800 mg q24h) in combination with amphotericin B deoxycholate (1 mg/kg q24h)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Fluconazole (1,200 mg q24h)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Fluconazole monotherapy (from meta-analysis)
Number of subjects: 43
Study: 27153252

Group type: EXPERIMENTAL
Intervention: Pork meals (n=19), provided four times/week for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Chicken meals (n=12), provided four times/week for 12 weeks
Number of subjects: 48
Study: 25351016

Group type: EXPERIMENTAL
Intervention: Mineral-rich mud compresses
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mineral-depleted compresses
Number of subjects: 44
Study: 22933808

Group type: EXPERIMENTAL
Intervention: Theta-band (2-6 Hz) oscillations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha-band (8-12 Hz) oscillations
Number of subjects: 0
Study: 21109913

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 60
Study: 18307772

Group type: EXPERIMENTAL
Intervention: 2 g FFA PinnoThin
Number of subjects: 42

Group type: COMPARATOR
Intervention: olive oil control
Number of subjects: 42
Study: 15756254

Group type: EXPERIMENTAL
Intervention: 8 weeks of outpatient subcutaneous interleukin‐2 (sc‐rIL‐2), subcutaneous interferon‐alpha2a (sc‐rIFN‐alpha2a), and intravenous 5‐fluorouracil (iv‐5‐FU) according to the standard Atzpodien regimen
Number of subjects: 203

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: 8 weeks of outpatient sc‐rIL‐2/sc‐rIFN‐alpha2a/iv‐5‐FU-based immunochemotherapy
Number of subjects: 203
Study: 12381971

Group type: EXPERIMENTAL
Intervention: Specific exercise program (experimental group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Commonly prescribed exercise program (control group)
Number of subjects: 20
Study: 10065646

Group type: EXPERIMENTAL
Intervention: Simultaneous placement of titanium implants
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Delayed placement of titanium implants
Number of subjects: 10
Study: 7772438

Group type: EXPERIMENTAL
Intervention: Hudson face mask (oxygen 3 litre min‐1, air 12 litre min‐1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nasal prong (oxygen 3 litre min‐1)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Binasal catheter (oxygen 3 litre min‐1)
Number of subjects: 25
Study: 1699272

Group type: EXPERIMENTAL
Intervention: Iloprost (2 ng/kg/min, intravenously for 6 hours daily for 28 days)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo (identical solvent volumes)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 1090318

Group type: EXPERIMENTAL
Intervention: Two layer technique
Number of subjects: 92

Group type: COMPARATOR
Intervention: One layer technique
Number of subjects: 92
Study: 30674284

Group type: EXPERIMENTAL
Intervention: Combined use of smartphone and smartband technology with brief counseling on life habits for 3 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: Counseling only
Number of subjects: 160
Study: 28422556

Group type: EXPERIMENTAL
Intervention: Sitting interrupted by 2 minutes of light-intensity walking every 20 minutes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sitting interrupted by 2 minutes of standing every 20 minutes
Number of subjects: 17

Group type: COMPARATOR
Intervention: Uninterrupted sitting
Number of subjects: 17
Study: 26109462

Group type: EXPERIMENTAL
Intervention: Patient navigation (PN) services including education, counseling, and logistical support in their language of choice
Number of subjects: 303

Group type: COMPARATOR
Intervention: Mailed cancer education materials (control group)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Patient navigation (PN)
Number of subjects: 303
Study: 23788695

Group type: EXPERIMENTAL
Intervention: Consciously resting meditation (CRM)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 68
Study: 21774916

Group type: EXPERIMENTAL
Intervention: Experiential self-focus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Analytical self-focus
Number of subjects: 0
Study: 19935461

Group type: EXPERIMENTAL
Intervention: Protocol Biopsies (PBx)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Angiotensin‐II‐converting enzyme inhibitors or angiotensin II receptor blockers
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no PBx)
Number of subjects: 218
Study: 17043957

Group type: EXPERIMENTAL
Intervention: Compression anastomosis clip (CAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stapler
Number of subjects: 40
Study: 12742466

Group type: EXPERIMENTAL
Intervention: 5 mg/d sirolimus
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: 2 mg/d sirolimus
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: sirolimus groups
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Global trial with sirolimus
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: sirolimus addition to CsA-Pred regimen
Number of subjects: 1300
Study: 10868702

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 9113932

Group type: EXPERIMENTAL
Intervention: High-dose sequential therapy
Number of subjects: 98
Study: 8239913

Group type: EXPERIMENTAL
Intervention: Tołpa Torf Preparation (TTP) administered orally, 5 mg daily for three weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Tołpa Torf Preparation (TTP)
Number of subjects: 39
Study: 3104124

Group type: EXPERIMENTAL
Intervention: TTS NTG 40 cm2 (releasing 20 mg of NTG over 24 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg SR
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg SR
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: TTS NTG and Nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 8
Study: 31479535

Group type: EXPERIMENTAL
Intervention: Achieving ≥10% weight loss in the first year after diagnosis
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Achieving ≥10% weight loss in the subsequent 1-5 years
Number of subjects: 867

Group type: COMPARATOR
Intervention: Maintaining the same weight
Number of subjects: 867
Study: 30600732

Group type: EXPERIMENTAL
Intervention: Narrow band imaging (NBI‐Z)
Number of subjects: 116
Study: 26205903

Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Protocol modifications allowing for inclusion of patients receiving aspirin
Number of subjects: 568

Group type: COMPARATOR
Intervention: Malaysian participants
Number of subjects: 568
Study: 24884942

Group type: EXPERIMENTAL
Intervention: Gene-based test for estimation of lung cancer risk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no gene-based test)
Number of subjects: 0
Study: 20500555

Group type: EXPERIMENTAL
Intervention: Training group (TG) - aerobic and strength exercises without vibration
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Vibration training group (VTG) - aerobic and strength exercises with vibration
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (CG) - low-intensity wellness program
Number of subjects: 151
Study: 19220383

Group type: EXPERIMENTAL
Intervention: Anastomotic-vaginal fistula (AVF)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Conventional leakage (CL)
Number of subjects: 390

Group type: COMPARATOR
Intervention: No leakage
Number of subjects: 390
Study: 18332071

Group type: EXPERIMENTAL
Intervention: TPA-based antibiotic lock (ABL)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Heparin-based antibiotic lock (ABL)
Number of subjects: 42
Study: 15976981

Group type: EXPERIMENTAL
Intervention: 7 French 6 mm tip cryothermal catheter
Number of subjects: 94

Group type: COMPARATOR
Intervention: 9 French 8 mm tip cryothermal catheter
Number of subjects: 94
Study: 11930970

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10066655

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 7593876

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Delayed-treatment control
Number of subjects: 156
Study: 1961617

Group type: EXPERIMENTAL
Intervention: Iris iridectomies or iridotomies using a discission knife
Number of subjects: 1346

Group type: COMPARATOR
Intervention: No iridectomy or large iris opening made with scissors
Number of subjects: 1346
Study: 6160353

Group type: EXPERIMENTAL
Intervention: N-allyl-clonidine (ST 567) 40 mg, i.v.
Number of subjects: 18
Study: 31374027

Group type: EXPERIMENTAL
Intervention: GnRH pulse therapy
Number of subjects: 220

Group type: COMPARATOR
Intervention: HCG/HMG combined treatment
Number of subjects: 220
Study: 29099829

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 25990940

Group type: EXPERIMENTAL
Intervention: Combined resistance and balance-jumping training (COMB)
Number of subjects: 145
Study: 23113645

Group type: EXPERIMENTAL
Intervention: SST augmented with intraoperative mitomycin-C (MMC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: SST using Ologen implant
Number of subjects: 60
Study: 21537938

Group type: EXPERIMENTAL
Intervention: Alcohol intake
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 32
Study: 19027977

Group type: EXPERIMENTAL
Intervention: Miglitol 150 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mitiglinide 30 mg/day
Number of subjects: 40
Study: 16269646

Group type: EXPERIMENTAL
Intervention: Recombinant factor VIIa (rFVIIa) administered intravenously within 4 hours of ICH onset
Number of subjects: 1018

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1018
Study: 11975864

Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (40 mg/day)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (39 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (127.3 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (higher dose)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cimicifugae racemosae rhizoma (all doses)
Number of subjects: 72
Study: 10585169

Group type: EXPERIMENTAL
Intervention: Fluid ingestion during a 90 min intermittent exercise protocol
Number of subjects: 9

Group type: COMPARATOR
Intervention: No fluid intake during a 90 min intermittent exercise protocol
Number of subjects: 9
Study: 7852113

Group type: EXPERIMENTAL
Intervention: Single dose total body irradiation (STBI)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Fractionated total body irradiation (FTBI)
Number of subjects: 171
Study: 2031813

Group type: EXPERIMENTAL
Intervention: Berman 11 Intubating Airway
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tongue traction method of fibreoptic intubation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Macintosh intubation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both fibreoptic techniques
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Berman airway and tongue traction
Number of subjects: 75
Study: 7346530

Group type: EXPERIMENTAL
Intervention: 250 mg Slo-Phyllin Gyrocap
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 300 mg Theo-dur tablet
Number of subjects: 8
Study: 31287046

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) of praziquantel, given annually or twice over 4 years
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: School-based or community-wide MDA
Number of subjects: 5
Study: 28674144

Group type: EXPERIMENTAL
Intervention: Facebook campaigns
Number of subjects: 1357

Group type: EXPERIMENTAL
Intervention: Internet and social media advertising
Number of subjects: 1357

Group type: EXPERIMENTAL
Intervention: Network strategies
Number of subjects: 1357

Group type: COMPARATOR
Intervention: Radio advertising
Number of subjects: 1357
Study: 26474603

Group type: EXPERIMENTAL
Intervention: Computerized decision support system (CDSS) NHGDoc
Number of subjects: 229